FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LADARIXIN
异名/同义词(R)-(-)-N-(2-(4-(TRIFLUOROMETHANESULFONYLOXY)PHENYL)PROPIONYL)METHANESULFONAMIDE
4-((2R)-1-OXO-1-(METHANESULFONAMIDO)PROPAN-2-YL)PHENYL TRIFLUOROMETHANESULFONATE
LADARIXIN
LADARIXIN [INN]
LADARIXIN [WHO-DD]
METHANESULFONIC ACID, 1,1,1-TRIFLUORO-, 4-((1R)-1-METHYL-2-((METHYLSULFONYL)AMINO)-2-OXOETHYL)PHENYL ESTER
METHANESULFONIC ACID, TRIFLUORO-, 4-((1R)-1-METHYL-2-((METHYLSULFONYL)AMINO)-2-OXOETHYL)PHENYL ESTER
CAS登记号849776-05-2
物质唯一标识(Unique Ingredient Identifier)DEH7Q6472O
分子式C11H12F3NO6S2
国际化合物标识(International Chemical Identifier,InChI)DDLPYOCJHQSVSZ-SSDOTTSWSA-N
SMILESO(c1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1)S(C(F)(F)F)(=O)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System